Study Evaluating the Efficacy of DVS-233 in Fibromyalgia
Clinical trial NCT00301431 · TERMINATED
Trial details
- NCT number
- NCT00301431
- Sponsor
- Wyeth is now a wholly owned subsidiary of Pfizer
- Status
- TERMINATED
- Phase
- Phase 2, Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2006-08-01
- Enrollment
- 1050
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.